Antibodies to fibrillarin, PM-Scl and RNA polymerase III detected by ELISA assays in patients with systemic sclerosis. 2010

Danilo Villalta, and Gabriella Morozzi, and Marilina Tampoia, and Claudia Alpini, and Ignazio Brusca, and Valeria Salgarolo, and Wolfgang Papisch, and Nicola Bizzaro
Allergologia e Immunologia Clinica, DML, A.O. S. Maria degli Angeli, Pordenone, Italy. danilo.villalta@aopn.fvg.it

BACKGROUND Anti-fibrillarin (AFA), anti-RNA polymerase (anti-RNAP), and anti-PM-Scl autoantibodies are useful markers for the diagnosis of systemic sclerosis (SSc) in patients who are anti-centromere- (ACA) or anti-topoisomerase I (anti-topo I)-negative, but, until recently, the only specific method for their identification was the radio-immunoprecipitation assay. The aim of this study was to evaluate the clinical accuracy of the new enzyme-linked immunosorbent assays (ELISA) developed by Phadia for their detection. METHODS Sera of 50 ACA and anti-topo I-negative SSc patients, and, as control group, sera of 122 patients (42 with SSc, ACA or anti-topo I-positive, 40 with systemic lupus erythematosus and 40 with rheumatoid arthritis) were studied. RESULTS Using the cutoff proposed by the manufacturer (10 AU/mL), sensitivity and specificity were: for AFA, 22% and 92.6%; for anti-RNAP, 16% and 97.5%; and for anti-PM-Scl, 8% and 98.8%, respectively. Using a cutoff corresponding to 98.8% specificity for all three antibodies, sensitivity was 10%, 14% and 8%, respectively. The combined use of these three antibody assays enabled identification of 32% of ACA- and anti-topo I-negative SSc patients. CONCLUSIONS These new ELISA methods for AFA, anti-RNAP III and anti-PM-Scl detection have good diagnostic specificity, and may help identify a subset of SSc patients ACA and anti-topo I-negative.

UI MeSH Term Description Entries
D009687 Nuclear Proteins Proteins found in the nucleus of a cell. Do not confuse with NUCLEOPROTEINS which are proteins conjugated with nucleic acids, that are not necessarily present in the nucleus. Nucleolar Protein,Nucleolar Proteins,Nuclear Protein,Protein, Nuclear,Protein, Nucleolar,Proteins, Nuclear,Proteins, Nucleolar
D002868 Chromosomal Proteins, Non-Histone Nucleoproteins, which in contrast to HISTONES, are acid insoluble. They are involved in chromosomal functions; e.g. they bind selectively to DNA, stimulate transcription resulting in tissue-specific RNA synthesis and undergo specific changes in response to various hormones or phytomitogens. Non-Histone Chromosomal Proteins,Chromosomal Proteins, Non Histone,Chromosomal Proteins, Nonhistone,Non-Histone Chromosomal Phosphoproteins,Chromosomal Phosphoproteins, Non-Histone,Non Histone Chromosomal Phosphoproteins,Non Histone Chromosomal Proteins,Nonhistone Chromosomal Proteins,Proteins, Non-Histone Chromosomal
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005095 Exoribonucleases A family of enzymes that catalyze the exonucleolytic cleavage of RNA. It includes EC 3.1.13.-, EC 3.1.14.-, EC 3.1.15.-, and EC 3.1.16.-. EC 3.1.- Exoribonuclease
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001323 Autoantibodies Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them. Autoantibody
D001324 Autoantigens Endogenous tissue constituents with the ability to interact with AUTOANTIBODIES and cause an immune response. Autoantigen,Autologous Antigen,Autologous Antigens,Self-Antigen,Self-Antigens,Antigen, Autologous,Antigens, Autologous,Self Antigen,Self Antigens
D012320 RNA Polymerase III A DNA-dependent RNA polymerase present in bacterial, plant, and animal cells. It functions in the nucleoplasmic structure where it transcribes DNA into RNA. It has specific requirements for cations and salt and has shown an intermediate sensitivity to alpha-amanitin in comparison to RNA polymerase I and II. DNA-Dependent RNA Polymerase III,RNA Polymerase C,DNA Dependent RNA Polymerase III,Polymerase C, RNA,Polymerase III, RNA
D012595 Scleroderma, Systemic A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA. Sclerosis, Systemic,Systemic Scleroderma,Systemic Sclerosis
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity

Related Publications

Danilo Villalta, and Gabriella Morozzi, and Marilina Tampoia, and Claudia Alpini, and Ignazio Brusca, and Valeria Salgarolo, and Wolfgang Papisch, and Nicola Bizzaro
July 2007, The Journal of rheumatology,
Danilo Villalta, and Gabriella Morozzi, and Marilina Tampoia, and Claudia Alpini, and Ignazio Brusca, and Valeria Salgarolo, and Wolfgang Papisch, and Nicola Bizzaro
July 2008, Rheumatology (Oxford, England),
Danilo Villalta, and Gabriella Morozzi, and Marilina Tampoia, and Claudia Alpini, and Ignazio Brusca, and Valeria Salgarolo, and Wolfgang Papisch, and Nicola Bizzaro
July 2010, Clinica chimica acta; international journal of clinical chemistry,
Danilo Villalta, and Gabriella Morozzi, and Marilina Tampoia, and Claudia Alpini, and Ignazio Brusca, and Valeria Salgarolo, and Wolfgang Papisch, and Nicola Bizzaro
January 2012, Clinical and experimental rheumatology,
Danilo Villalta, and Gabriella Morozzi, and Marilina Tampoia, and Claudia Alpini, and Ignazio Brusca, and Valeria Salgarolo, and Wolfgang Papisch, and Nicola Bizzaro
January 2009, Arthritis research & therapy,
Danilo Villalta, and Gabriella Morozzi, and Marilina Tampoia, and Claudia Alpini, and Ignazio Brusca, and Valeria Salgarolo, and Wolfgang Papisch, and Nicola Bizzaro
July 2021, Clinical rheumatology,
Danilo Villalta, and Gabriella Morozzi, and Marilina Tampoia, and Claudia Alpini, and Ignazio Brusca, and Valeria Salgarolo, and Wolfgang Papisch, and Nicola Bizzaro
October 2019, Kidney international reports,
Danilo Villalta, and Gabriella Morozzi, and Marilina Tampoia, and Claudia Alpini, and Ignazio Brusca, and Valeria Salgarolo, and Wolfgang Papisch, and Nicola Bizzaro
March 2021, Annals of agricultural and environmental medicine : AAEM,
Danilo Villalta, and Gabriella Morozzi, and Marilina Tampoia, and Claudia Alpini, and Ignazio Brusca, and Valeria Salgarolo, and Wolfgang Papisch, and Nicola Bizzaro
June 2022, Archives of rheumatology,
Danilo Villalta, and Gabriella Morozzi, and Marilina Tampoia, and Claudia Alpini, and Ignazio Brusca, and Valeria Salgarolo, and Wolfgang Papisch, and Nicola Bizzaro
February 2015, The Journal of dermatology,
Copied contents to your clipboard!